Northwire Canada EditionFriday, July 10, 2026
Sign inSubscribe
Northwire
⌕
FCI 0.400 −9.1% GR 0.075 +0.0% AII 22.35 +7.5% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.28 −2.3% SGZ 0.045 +0.0% S 0.135 +12.5% GRSL 0.310 −3.1% DEX 0.390 +1.3% WMS 0.040 +0.0% EMPR 0.840 +2.4% SAGA 0.480 +0.0% ABX 51.59 −1.2% FCI 0.400 −9.1% GR 0.075 +0.0% AII 22.35 +7.5% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.28 −2.3% SGZ 0.045 +0.0% S 0.135 +12.5% GRSL 0.310 −3.1% DEX 0.390 +1.3% WMS 0.040 +0.0% EMPR 0.840 +2.4% SAGA 0.480 +0.0% ABX 51.59 −1.2%
Regulatory Admin

Canadian Investment Regulatory Organization Trading Halt - CURE.X

By The Northwire Desk — AI Analysis Jun 22, 2026 · 09:18 CURE · 0.015 Biocure Technology Inc.
CURE · Price

Executive Summary

  • The Canadian Investment Regulatory Organization (CIRO) has imposed a temporary trading halt on all issues of Biocure Technology Inc. (CSE: CURE.X) to maintain a fair and orderly market while pending material news is prepared for release.
  • Trading was suspended at 9:08 AM ET on June 22, 2026, and will remain halted until the regulatory suspension is lifted and the pending disclosure is disseminated to the public.
  • CIRO staff are unable to provide additional details regarding the halt or the nature of the pending news; market participants should monitor official exchange channels for the subsequent material news release.

Key Details

  • Company: Biocure Technology Inc.
  • CSE Symbol: CURE.X
  • Halt Reason: Pending News
  • Halt Time (ET): 9:08 AM on June 22, 2026
  • Scope: All issued and outstanding securities of the company
  • Regulatory Authority: Canadian Investment Regulatory Organization (CIRO)
  • Policy Reference: CIRO Trading Halts & Timely Disclosure guidelines
  • Investor Guidance: No additional information regarding the halt or pending news will be provided by CIRO beyond this notice; investors should contact the company directly for general enquiries.
Read the original news release →

More from Biocure Technology Inc.

Jun 22, 2026 · 21:40

Biocure’s reverse takeover rescues cash-strapped shell with Korean MMA venture, but leaves existing holders owning just 8%

M&A / Property May 08, 2026 · 16:15

Biocure Technology Inc. Announces Adoption of Semi-Annual Reporting

Other Aug 05, 2025 · 03:17

Biocure shareholders approve all matters at AGM

Regulatory